Sermorelin research: growth hormone releasing hormone analog
Sermorelin research explained: GHRH analog signaling, pituitary GH release, and how it compares with CJC-1295 and tesamorelin.
Sermorelin research explained: GHRH analog signaling, pituitary GH release, and how it compares with CJC-1295 and tesamorelin.
Ipamorelin selectivity explained for researchers: ghrelin receptor signaling, GH release, and why it differs from older GHRPs.
CJC-1295 with and without DAC explained for researchers: half-life, albumin binding, pulsatile GH release, and key study differences.
Tesamorelin research guide: the FDA-approved GHRH analog, mechanism of action, lipodystrophy research, metabolic effects, and how it compares to sermorelin and CJC-1295.
Sermorelin research guide: GHRH(1-29) mechanism, pituitary function support, age-related GH decline research, and how it compares to Tesamorelin and CJC-1295.
Ipamorelin research guide: the first selective GH secretagogue, ghrelin receptor mechanism, comparison with CJC-1295, and what the clinical research shows.
CJC-1295 No DAC research guide: GHRH analog mechanism, pulsatile GH release studies, comparison with Ipamorelin, and what the published research shows.